Literature DB >> 29382195

Vx3-Functionalized Alumina Nanoparticles Assisted Enrichment of Ubiquitinated Proteins from Cancer Cells for Enhanced Cancer Immunotherapy.

Jinjin Zhao1, Ning Pan1, Fang Huang1, Mohanad Aldarouish1, Zhifa Wen1, Rong Gao1, Yuye Zhang2, Hong-Ming Hu1,3, Yanfei Shen4, Li-Xin Wang1.   

Abstract

A simple and effective strategy was developed to enrich ubiquitinated proteins (UPs) from cancer cell lysate using the α-Al2O3 nanoparticles covalently linked with ubiquitin binding protein (Vx3) (denoted as α-Al2O3-Vx3) via a chemical linker. The functionalized α-Al2O3-Vx3 showed long-term stability and high efficiency for the enrichment of UPs from cancer cell lysates. Flow cytometry analysis results indicated dendritic cells (DCs) could more effectively phagocytize the covalently linked α-Al2O3-Vx3-UPs than the physical mixture of α-Al2O3 and Vx3-UPs (α-Al2O3/Vx3-UPs). Laser confocal microscopy images revealed that α-Al2O3-Vx3-UPs localized within the autophagosome of DCs, which then cross-presented α-Al2O3-Vx3-UPs to CD8+ T cells in an autophagosome-related cross-presentation pathway. Furthermore, α-Al2O3-Vx3-UPs enhanced more potent antitumor immune response and antitumor efficacy than α-Al2O3/cell lysate or α-Al2O3/Vx3-UPs. This work highlights the potential of using the Vx3 covalently linked α-Al2O3 as a simple and effective platform to enrich UPs from cancer cells for the development of highly efficient therapeutic cancer vaccines.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29382195     DOI: 10.1021/acs.bioconjchem.7b00578

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  5 in total

1.  Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells.

Authors:  Heng Dong; Zhi-Fa Wen; Lin Chen; Na Zhou; Hui Liu; Shiling Dong; Hong-Ming Hu; Yongbin Mou
Journal:  Int J Nanomedicine       Date:  2018-06-07

Review 2.  Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?

Authors:  Nataschja I Ho; Lisa G M Huis In 't Veld; Tonke K Raaijmakers; Gosse J Adema
Journal:  Front Immunol       Date:  2018-12-13       Impact factor: 7.561

3.  Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells.

Authors:  Fang Huang; Jinjin Zhao; Yiting Wei; Zhifa Wen; Yue Zhang; Xuru Wang; Yanfei Shen; Li-Xin Wang; Ning Pan
Journal:  Int J Nanomedicine       Date:  2020-02-13

4.  Triggered Immune Response Induced by Antigenic Epitopes Covalently Linked with Immunoadjuvant-Pulsed Dendritic Cells as a Promising Cancer Vaccine.

Authors:  Chumeng Chen; Mohanad Aldarouish; Qilong Li; Xiangzhen Liu; Feng Han; Hui Liu; Qijun Qian
Journal:  J Immunol Res       Date:  2020-04-04       Impact factor: 4.818

5.  Effects of Combinatorial Ubiquitinated Protein-Based Nanovaccine and STING Agonist in Mice With Drug-Resistant and Metastatic Breast Cancer.

Authors:  Fang Huang; Ning Pan; Yiting Wei; Jinjin Zhao; Mohanad Aldarouish; Xuru Wang; Xiaotong Sun; Zhifa Wen; Yongqiang Chen; Lixin Wang
Journal:  Front Immunol       Date:  2021-09-13       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.